Final Cp Proposal 2022 (1)

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 48

BACTERIOLOGIC AND CLINICAL PROFILE OF

NEONATAL SEPSIS IN A TERTIARY HOSPITAL


IN VALENZUELA CITY: A RETROSPECTIVE
STUDY
Principal Investigator: Gian Ysmael B. Tejada M.D
INTRODUCTION
• Sepsis is the most common • Remarkable
cause of neonatal morbidity developments have been
made in recent years to
and mortality. reduce the number of
neonatal deaths globally.
• Neonatal sepsis is a
generalized bacterial
infection documented by a
positive blood culture in the
first four weeks of life,
along with a clinical
syndrome characterized by
systemic signs of infection.
Classifications of neonatal sepsis
1. Early onset neonatal sepsis – with signs of infection <72
hours of life. Usually results from organisms acquired
intrapartum.

2. Late onset neonatal sepsis- with signs of infection > 72


hours of life. Usually acquired from the environment.
NEONATAL SEPSIS
>There is remarkable
heterogeneity among studies
regarding the case definition of
neonatal sepsis.

>The “gold standard” in


diagnosing Neonatal sepsis is
the presence of a positive blood
culture.

>Negative blood and other


sterile site cultures with
manifesting signs consistent
with infection may be
considered to have “clinical”
sepsis.
NEONATAL SEPSIS
>Evidence of *SIRS in both
adult and pediatric consensus is
a prerequisite to meet the
criteria for sepsis.

*SIRS requires either 1) abnormal


WBC count [total WBC increased or
decreased for age -or- >10%
immature neutrophils] or 2)
abnormal core temperature (>38.5°
or <36°C).
NEONATAL SEPSIS
> International data are difficult to standardize in the
absence of unified criteria for neonatal sepsis. Recently, in adults,
the Third International Consensus Definitions for Sepsis and Septic
Shock (Sepsis-3) have defined sepsis as a life-threatening organ
dysfunction caused by a dysregulated response to infection.

>The new consensus definition moved away from the concept of


systemic inflammatory response syndrome, which formed part of
the definition of sepsis in the past 20 years.

>The criteria to define infection and sepsis are essential


in the neonatal population to limit over diagnosis, but they are not
part of the adult Sepsis-3 definitions.

> CONCLUSION: There are multiple definitions of


neonatal sepsis used internationally that encompass clinical,
microbiological and biochemical data as well as treatment
initiation and duration.

>consensus definition is required that can


be universally generalizable and validated in international datasets.
BACKGROUND
In 2013 however, 44% of deaths in children under five
occurred during the neonatal period (up from 37% in 1990).

It was found that the three major causes of neonatal deaths


worldwide were infection from neonatal sepsis/pneumonia
(36%), pre-term birth (28%), and birth asphyxia (23%).
BACKGROUND
Bacterial infections are the primary cause of death in
term-infants, pneumonia being responsible for 19%, neonatal
tetanus for 14%, sepsis/meningitis for 7% and diarrhea for 2% of
the deaths…

In developing countries, the incidence of neonatal


sepsis ranges from 7.8 to 21.8/1000 live births, with case fatality
rates as high as 38%.

The WHO estimates that > 1 million neonatal deaths worldwide


annually are caused by severe infections and 1 million deaths are due
to neonatal sepsis and pneumonia alone.
• Despite major advances and increasing research in neonatal care in developed
countries, 40% of neonates with sepsis die or experience a major disability
such as neurodevelopmental impairment.

• In 2017, newborn deaths further increased and accounted for 45% of under-five
deaths globally.

• In the Philippines, report from the UNICEF showed that neonatal sepsis
accounts for 13% of neonatal deaths and 10-12% of all causes of deaths in
the country.
• Common laboratory tests such as complete blood count, C-reactive
protein, and erythrocyte sedimentation rate are used to aid in diagnosis,
even if they have limited diagnostic accuracy for neonatal sepsis.

• The gold standard for diagnosing neonatal sepsis is still blood culture
despite its low sensitivity - majority of sepsis cases are diagnosed in the
presence of concerning clinical signs with negative culture results.
• The limitations of ancillary tests and the low sensitivity of blood culture
combined with non-specific clinical signs constrain clinicians to treat
patients based on a high level of suspicion.

• This necessitates initiation of empiric antibiotic therapy until sepsis is


ruled out.
• The diversity of organisms causing neonatal sepsis varies from one
hospital to another and can change over time in the same location.

• Although most isolates remain sensitive to newer antibiotics,


emergence of resistant strains is a potential problem due to changing
patterns of antibiotic use.
• The subtle and non-specific symptomatology of sepsis causes difficulty in
early detection and timely treatment.

• The pathogens causing sepsis in the newborn and the antibiotic


susceptibility varies from one hospital to another.

• Prompt treatment based on a rational protocol according to antibiotic


susceptibility will greatly help in reducing morbidity and mortality from
neonatal sepsis.
• The risk of overuse of antibiotics are well described in the era of antibiotic
resistance and the negative effects of altering the microbiome include an
increased rate of serious complications including mortality and necrotizing
enterocolitis association with antibiotic exposure.
LOCAL SETTING
(VALENZUELA MEDICAL CENTER)

2021..

• 300 blood culture requested in


neonates suspected with
neonatal sepsis.

• 12 neonatal mortalities.
GENERAL OBJECTIVES
To determine the most common bacterial pathogens, their
etiology, and their antibiotic susceptibility pattern of neonatal sepsis in
Valenzuela Medical Center from January 1 to December 31, 2021.

SPECIFIC OBJECTIVES
1. To determine the bacteriologic profile of blood cultures of neonates
diagnosed with neonatal sepsis.
2. To determine the antibiotic susceptibility pattern of the top
microorganisms of neonates diagnosed with neonatal sepsis.
3. To detect the positivity rate of blood culture specimens from neonates
diagnosed with neonatal sepsis.
4. To determine the risk factors associated with neonatal sepsis.
5. To identify clinical presentations of patients clinically diagnosed with
neonatal sepsis.
RESEARCH QUESTION
What are the most common bacterial etiology and their antibiotic
susceptibility pattern of neonates diagnosed with neonatal sepsis in
Valenzuela Medical Center from January 1 to December 31, 2021?
HYPOTHESIS
NULL HYPOTHESIS
There are no commonly identified bacteria with their antibiotic
susceptibility pattern in neonates diagnosed with neonatal sepsis in
Valenzuela Medical Center.

ALTERNATIVE HYPOTHESIS
There are commonly identified bacterial with their antibiotic
susceptibility pattern in neonates diagnosed with neonatal sepsis in
Valenzuela Medical Center.
SIGNIFICANCE OF THE STUDY

• Provides guidance to clinicians for empiric therapy of infection before the


causative agent has been identified.

• Provides direct therapy after an organism has been identified but before
susceptibility tests have been completed.

• Promotes cost-efficient medical management.

• Increase survival rate of neonates with sepsis.

• The pathogens causing sepsis in the newborn and the antibiotic susceptibility
varies from one hospital to another. Prompt treatment based on a rational
protocol according to antibiotic susceptibility will greatly help in reducing
morbidity from neonatal sepsis.
OPERATIONAL DEFINITION

1. Antibiotics- a drug that inhibits growth of a bacteria.


2. Blood culture (Positive)- growth of bacteria detected in the blood
specimen after 4 days of incubation.
3. Blood culture (Negative)- absence of bacterial growth in the blood
specimen after 4 days of incubation.
4. Clinical Sepsis- the presence of infection which requires the following
criteria: Hypothermia (<36), poor feeding, distended abdomen, apneic
episodes, grunting, central cyanosis, jaundice. Not necessary
documented by positive blood culture.
5. Culture Positive Sepsis- generalized bacterial infection documented by
a positive blood culture.
6. Neonates- a child under 28 days of age.
OPERATIONAL DEFINITION

7. Antibiotic Resistance- ability of bacteria to resist inhibitory effect of


potential antibiotics.
8. Antibiotic Sensitivity- ability of an antibiotic to inhibit bacterial growth.
9. Neonatal sepsis- generalized bacterial infection in the first 28 days of life,
characterized by systemic signs of infection.
10. Bacterial etiology- bacteria identified thru blood culture.
11. Systemic Inflammatory Response Syndrome (SIRS) – requires either
abnormal WBC count or abnormal core temperature (>38.5 or <36)
REVIEW OF
RELATED
LITERATURE
METHODOLOGY
RESEARCH DESIGN AND SETTING

This will be a retrospective descriptive study of neonatal sepsis cases in


Valenzuela Medical Center from January 1 to December 31 2021.
INCLUSION CRITERIA

• All neonates admitted in Valenzuela Medical Center from January 1 to


December 31, 2021 that were clinically diagnosed with suspected
neonatal sepsis.

• Neonates who had blood culture and sensitivity done before antibiotics
were started.
EXCLUSION CRITERIA

• Neonates who received antibiotics prior to hospital admission.

• Neonates with blood culture results done in an institution other than


Valenzuela Medical Center.
DATA COLLECTION

• In-patient records of neonates who were admitted and clinically


diagnosed with neonatal sepsis will be reviewed and analyzed.

• Details in the history including maternal risk factors, mode of delivery,


gestational age, birth weight, birth setting, and clinical manifestations will
be recorded.

• Data on Antimicrobial etiology, blood culture and sensitivity will be


recorded.
SAMPLE POPULATION

The sample size will be taken using a census


(complete enumeration). A total census will be
taken from the year January 1, 2021 to December
31, 2021. All documents qualified in our inclusion
criteria will be used for the study.
ALTERNATIVE SAMPLE SIZE
DETERMINATION

Assuming a confidence level of 95 % and a confidence interval of 5 on a


300 sample population, 169 is the recommended sample size given the
conditions selected.
STATISTICAL TOOL

Descriptive statistics will be used in the data analysis.


To determine the susceptibility between the microorganisms to the different
antibiotics, Chi-square will be used with the following formula:

Where:
X2 is the Chi-Square value
O is the observed frequency
E is the expected frequency
ETHICAL CONSIDERATION

• The study will involve de-identified data on patient profile, blood culture
and sensitivity results from previously managed VMC patients to be
retrieved from hospital records and microbiology section, thus posing no
risk on subjects involved.

• The study protocol will be submitted to VMC’s Ethics Review Board for
approval prior to data gathering.
PRESENTATION,
ANALYSIS AND
INTERPRETATIO
N OF RESULTS
(DUMMY
TABLES)
TABLE 1. GENDER DISTRIBUTION

TOTAL SUSPECTED CULTURE POSITIVE CULTURE NEGATIVE

MALE

FEMALE

TOTAL
TABLE 2. DISTRIBUTION BASED ON
PRESENTING CLINICAL SIGNS
CLINICAL FEATURE SUSPECTED CASE Culture Positive Culture Negative
Respiratory distress
Fever
Jaundice
Poor feeding
Lethargy
Vomiting
Diarrhea
Cyanosis
Apnea
TABLE 3. DISTRIBUTION BASED ON
ASSOCIATED RISK FACTORS
RISK FACTORS SUSPECTED CASE Culture Positive Culture Negative
PROM
MATERNAL
CHORIOAMNIONITIS
Non-institutional
delivery
Prolonged use of iv
catheters
Prolonged
hospitalization
Low birth weight
Preterm
TABLE 4. Frequency of bacterial isolates

Bacteria Frequency Total


Gram positive
Staphylococcus aureus
GBS

Gram Negative
Klebsiella
E.coli
Enterobacter cloacae
TABLE 5. ANTIBIOTIC SUSCEPTIBILITY
PATTERN

ANTIBIOTIC BACTERIA 1 BACTERIA 2 BACTERIA 3


BUDGET
AMOUNT

Statistician 10,000

Office materials 2,000

Services 2,000
- Computer use, data storage
- - duplication services (reports, etc)

total 14,000
TIMETABLE
Activities (2021) APRIL 2022 MAY 2022 JUNE 2022 JULY 2022 AUGUST 2022

Approval of
protocol by
Ethics Review
Board

Data collection

Data analysis

Submission of
final paper
THANK YOU !

You might also like